Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer

Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small... ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog Shim, MD,* Sun Young Jeong, MD,† Kyung Soo Lee, MD,† O Jung Kwon, MD,‡ and Jhingook Kim, MD* ith recent advances in diagnostic imaging technologies, Introduction: When pure ground-glass opacity (GGO) lesions are Wground-glass opacity (GGO) lesions have been increas- detected in patients with otherwise operable non-small cell lung ingly detected on high-resolution computed tomography cancer, it is controversial whether to resect them simultaneously 1–4 (HRCT) scans. Because GGO lesions suggest early non- with the primary tumor or not. small cell lung cancer (NSCLC), especially adenocarcinoma, Methods: We retrospectively reviewed radiologic features and many studies have investigated their morphologic features pathologic diagnoses of pure GGO lesions detected in otherwise 5–11 and histologic diagnoses. Nevertheless, when patients operable non-small cell lung cancer. Forty lesions were identified in diagnosed with NSCLC have GGO lesions in addition to the 23 patients. Four of the eight lesions that were simultaneously primary tumor, little is known about their clinical, radiologic, resected at surgery for the primary tumor turned out to be malignant. and pathologic http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer

Kim, Jhingook
Journal of Thoracic Oncology , Volume 4 (10) – Oct 1, 2009
Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/management-of-ground-glass-opacity-lesions-detected-in-patients-with-voz4jYMqm0

References (21)

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181b3fee3
pmid
19687762
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Management of Ground-Glass Opacity Lesions Detected in Patients with Otherwise Operable Non-small Cell Lung Cancer Hong Kwan Kim, MD,* Yong Soo Choi, MD,* Kwhanmien Kim, MD,* Young Mog Shim, MD,* Sun Young Jeong, MD,† Kyung Soo Lee, MD,† O Jung Kwon, MD,‡ and Jhingook Kim, MD* ith recent advances in diagnostic imaging technologies, Introduction: When pure ground-glass opacity (GGO) lesions are Wground-glass opacity (GGO) lesions have been increas- detected in patients with otherwise operable non-small cell lung ingly detected on high-resolution computed tomography cancer, it is controversial whether to resect them simultaneously 1–4 (HRCT) scans. Because GGO lesions suggest early non- with the primary tumor or not. small cell lung cancer (NSCLC), especially adenocarcinoma, Methods: We retrospectively reviewed radiologic features and many studies have investigated their morphologic features pathologic diagnoses of pure GGO lesions detected in otherwise 5–11 and histologic diagnoses. Nevertheless, when patients operable non-small cell lung cancer. Forty lesions were identified in diagnosed with NSCLC have GGO lesions in addition to the 23 patients. Four of the eight lesions that were simultaneously primary tumor, little is known about their clinical, radiologic, resected at surgery for the primary tumor turned out to be malignant. and pathologic

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Oct 1, 2009

There are no references for this article.